| |
| |
|
| Insider
Information: |
Myers Scott Dunseth |
| Relationship: |
|
| City: |
Hackensack |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
360,434 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,608,312 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
360,434 |
|
|
| Total
Value |
$3,608,312 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -28.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cascadian Therapeutics, Inc |
CASC |
President and CEO, Dir... |
2018-03-09 |
0 |
2016-06-28 |
0 |
Premium* |
|
|
Selecta Biosciences Inc |
SELB |
Director |
2019-12-23 |
80,845 |
2019-08-20 |
0 |
Premium* |
|
|
Viridian Therapeutics Ors Shs |
VRDN |
|
2023-04-12 |
259,500 |
2023-02-06 |
0 |
Premium* |
|
|
Dynavax Technologies Corp |
DVAX |
Director |
2023-05-26 |
20,089 |
2023-05-26 |
0 |
Premium* |
|
|
Harpoon Therapeutics, Inc. |
HARP |
|
2024-03-11 |
0 |
2023-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HARP |
Harpoon Therapeutics, Inc... |
|
– • – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,665) |
0 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
|
– • – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,048 |
22,666 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • – |
2023-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
20,618 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • – |
2023-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,797 |
15,618 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • – |
2023-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
35,634 |
98,215 |
0 |
- |
|
| DVAX |
Dynavax Technologies Corp |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,357 |
20,089 |
0 |
- |
|
| VRDN |
Viridian Therapeutics Ors... |
Chief Executive Officer |
• • – |
2023-04-12 |
4 |
B |
$25.37 |
$101,479 |
D/D |
4,000 |
259,500 |
0.01 |
% |
|
| VRDN |
Viridian Therapeutics Ors... |
Chief Executive Officer |
• • – |
2023-03-13 |
4 |
B |
$29.15 |
$160,324 |
D/D |
5,500 |
255,500 |
0.01 |
% |
|
| VRDN |
Viridian Therapeutics Ors... |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
250,000 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2019-12-23 |
4 |
A |
$1.46 |
$57,537 |
D/D |
39,409 |
80,845 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2019-08-20 |
4 |
A |
$1.81 |
$74,999 |
D/D |
41,436 |
41,436 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
President and CEO |
• • – |
2018-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(56,787) |
0 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
President and CEO |
• • – |
2018-01-11 |
4 |
D |
$3.92 |
$13,442 |
D/D |
(3,429) |
56,787 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
President and CEO |
• • – |
2018-01-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,500 |
60,216 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
President and CEO |
• • – |
2017-08-11 |
4 |
B |
$3.74 |
$20,543 |
D/D |
5,500 |
49,716 |
2.81 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
President and CEO |
• • – |
2017-05-12 |
4 |
B |
$4.00 |
$11,192 |
D/D |
2,800 |
44,216 |
2.81 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
President and CEO |
• • – |
2017-03-31 |
4 |
B |
$4.11 |
$8,229 |
D/D |
2,000 |
41,416 |
2.81 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
President and CEO |
• • – |
2017-03-20 |
4 |
B |
$3.93 |
$3,927 |
D/D |
1,000 |
39,416 |
2.73 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
President and CEO |
• • – |
2017-01-27 |
4 |
B |
$3.76 |
$77,039 |
D/D |
20,500 |
38,416 |
2.81 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
President and CEO |
• • – |
2016-08-17 |
4 |
B |
$1.15 |
$51,746 |
D/D |
45,000 |
107,500 |
2.81 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
President and CEO |
• • – |
2016-06-28 |
4 |
B |
$0.80 |
$50,000 |
D/D |
62,500 |
62,500 |
2.81 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
